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We write in agreement with Lamm et al in proposing a new standard definition for progression in 18 
non-muscle-invasive bladder cancer (NMIBC)1. We too recognised that defining a state of 19 
progression before the development of muscle-invasion would be a useful tool for clinical trials in 20 
NMIBC. Consequently, in 2005 we went through a very similar process to Lamm et al when writing 21 
the protocol for the West Midlands’ (UK) Bladder Cancer Prognosis Programme (BCPP, incorporating 22 
the SELENIB clinical trial), defining progression as “a recurrence with an increase in tumour grade 23 
from 1/2 to grade 3, or an increase in TNM stage, or the new occurrence of carcinoma in situ (CIS) in 24 
a bladder previously free from such lesions, or the new occurrence of multiple tumours following 25 
resection of a solitary tumour, or the need for a cystectomy because of refractory disease”3. Clearly, 26 
there are many similarities between our definition of progression for the purposes of BCPP/SELENIB 27 
and that proposed by Lamm et al, and we support their rationale and endeavour1. As we have 28 
observed with the change in terminology from “superficial bladder cancer” to “NMIBC” over the last 29 
ten years or more4,5, the key to adoption is utilising a term which is universally applicable and 30 
acceptable. In BCPP/SELENIB we have always qualified our definition of progression by describing it 31 
as “biological progression”. Perhaps “biological progression” could be the term that best describes 32 
Lamm et al’s new definition?   33 
 34 
35 
3 
 
References 36 
 37 
 1.  Lamm, D., Persad, R., Brausi, M., Buckley, R., Witjes, J. A., Palou, J. et al.: Defining Progression 38 
in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition. J Urol, 39 
2013. 40 
 2.  Wallace, D. M., Bryan, R. T., Dunn, J. A., Begum, G., and Bathers, S.: Delay and survival in 41 
bladder cancer. BJU Int, 89: 868, 2002. 42 
 3.  Zeegers, M. P., Bryan, R. T., Langford, C., Billingham, L., Murray, P., Deshmukh, N. S. et al.: The 43 
West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU Int, 44 
105: 784, 2010. 45 
 4.  Bryan, R. T. and Wallace, D. M.: 'Superficial' bladder cancer - time to uncouple pT1 tumours 46 
from pTa tumours. BJU Int, 90: 846, 2002. 47 
 5.  Bryan, R. T. and Wallace, D. M.: Have We Abandoned the "Superficial" in Bladder Cancer? Eur 48 
Urol, 2009. 49 
 50 
 51 
